Ignite Creation Date:
2024-05-06 @ 3:44 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04732598
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-11-15
First Post:
2021-01-28
Brief Title:
A Phase III Study of Bevacizumab and Paclitaxel in Combination With Atezolizumab as a Treatment for Locally Advanced Unresectable or Metastatic Hormone Receptor-positive HER2 Negative Breast Cancer
Sponsor:
Japanese Foundation for Cancer Research
Organization:
Japanese Foundation for Cancer Research
Organization Data
Organization:
Japanese Foundation for Cancer Research
Class:
OTHER
Study ID:
JCOG1919E
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Japanese Foundation for Cancer Research
Lead Sponsor Class:
OTHER
Responsible Party:
Fumikata Hara
Responsible Party Title:
MD PhD Chief Breast Medical Oncology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Japanese Foundation for Cancer Research
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Chugai Pharmaceutical | INDUSTRY |